EPAS1 and fatty liver disease: This finding is of interest as HIF-2 activation was reported to affect lipid metabolism in hepatocytes causing a decrease in lipogenic gene expression and on a physiological level, leading to hepatic steatosis in liver-specific Hif-2α mutant mice [21].